Lab
Seacoast Pathology INC
Seacoast Pathology INC was paid $995K by Medicaid between Jan 2018 and Dec 2024, across 24 billing codes. Its largest line is 87624, Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types — 29% of everything it billed.
33Billing provider infoSEACOAST PATHOLOGY INC
EXETER, NH 03833
EXETER, NH 03833
33aNPI1790996882assigned 05/24/2007
33bProvider typeClinical Medical Laboratory
28Total paid$995K
24GClaims52,298
24DCodes billed24
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in New Hampshire
Rank by total paid#1 of 6
Median peer was paid$31K
This provider vs. median32×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,488 | $36K | |
| 2019 | 4,846 | $106K | |
| 2020 | 5,303 | $112K | |
| 2021 | 11,528 | $231K | |
| 2022 | 14,929 | $302K | |
| 2023 | 7,571 | $112K | |
| 2024incomplete | 5,633 | $96K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 29% | 13,952 | 12,698 | $293K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 29% | 14,603 | 13,661 | $288K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 10% | 6,162 | 5,098 | $104K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 9.6% | 5,067 | 4,524 | $95K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 9.2% | 4,862 | 4,373 | $92K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 2.6% | 468 | 322 | $26K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.6% | 776 | 694 | $16K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1.2% | 797 | 285 | $12K |
| 87660 | 1.2% | 1,098 | 897 | $12K | |
| 87510 | 1.2% | 1,104 | 901 | $12K | |
| 87480 | 1.2% | 1,082 | 883 | $12K | |
| 88342 | 1.1% | 662 | 556 | $11K |
12 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVALLADARES, DINA (DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Memphis Pathology Laboratory | Memphis, TN | $61.43M |
| Propath Services, LLC | Dallas, TX | $16.79M |
| Pinkus Dermatopathology Laboratory, PC | Monroe, MI | $816K |
| Bernhardt Laboratories INC | Jacksonville, FL | $620K |
| Cleveland Skin Pathology Laboratory, INC | Beachwood, OH | $609K |
| Carla B. Macleod M.D. & Associates LLC | Gaithersburg, MD | $292K |
| Biopsy Diagnostics, LLC | Ridgeland, SC | $255K |
| Pinkus Dermatopathology Laboratory, PC | Monroe, MI | $93K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.